Assessment of coagulation and platelet activation in coronary sinus blood induced by transcatheter coronary intervention for narrowing of the left anterior descending coronary artery

American Journal of Cardiology

Volumn 85, Issue 2, 2000, Pages 154-160

  Mizuno, Osamu ^a   Hojo, Yukihiro ^a   Ikeda, Uichi ^a   Katsuki, Taka Aki ^a   Fukazawa, Hiroshi ^a   Kurosaki, Kenji ^a   Fujikawa, Hideyuki ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA THROMBOGLOBULIN; DILTIAZEM; HEPARIN; ISOSORBIDE DINITRATE; MARKER; NIFEDIPINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4; THROMBOPLASTIN; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; ATHERECTOMY; BLOOD; BLOOD CLOTTING; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SURGERY; CORONARY ARTERY THROMBOSIS; CORONARY SINUS; CORONARY STENT; ELECTIVE SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOSTASIS; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VESSELS; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION;

EID: 0033976418     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00651-7     Document Type: Article

References (25)

1. Gasperetti C.M., Gonias S.L., Gimple L.W., Powers E.R. Platelet activation during coronary angioplasty in humans. Circulation. 88:1993;2728-2734.
2. Vaitkus P.T., Watkins M.W., Witmer W.T., Tracy R.P., Sobel B.E. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty. Coron Artery Dis. 6:1995;587-592.
3. Coris W.J., Sütsch G., Murakami T., Krogmann O.N., Turina M., Hess O.M. Left ventricular function in chronic mitral regurgitation:preoperative and postoperative comparison. J Am Coll Cardiol. 25:1995;113-121.
4. Serrano C. Jr, Ramires J.A.F., Venturinelli M., Arie S., D'Amico E., Zweier J.L., Pileggi F., da Luz P.L. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. J Am Coll Cardiol. 29:1997;1276-1283.
5. Scharf R.E., Tomer A., Marzec U.M., Teirstein P.S., Ruggeri Z.M., Harker L.A. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arteioscler Thromb. 12:1992;1475-1487.
6. Marmur J.D., Merlini P.A., Sharma S.K., Khaghan N., Torre S.R., Israel D.H., Ardissino D., Ambrose J.A. Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty. J Am Coll Cardiol. 15:1994;1484-1491.
7. Golino P., Piscione F., Benedict C.R., Anderson H.V., Cappelli-Bigazzi M., Indolfi C., Condorelli M., Chiariello M., Willerson J.T. Local effect of serotonin released during coronary angioplasty. N Engl J Med. 330:1994;523-528.
8. Daniel T.O., Gibbs V.C., Milfay D.F., Garovoy M.R., Williams L.T. Thrombin stimulates c-sis gene expression in microvascular endothelial cells. J Biol Chem. 261:1986;9579-9582.
9. Daniel T.O., Gibbs V.C., Milfay D.F., Williams L.T. Agents that increase cAMP accumulation block endothelial c-sis induction by thrombin and transforming growth factor-β J Biol Chem. 262:1987;11893-11896.
10. Berk B.C., Taubman M.B., Cragoe E.J. Jr, Fenton J.W. II, Griendling K.K. Thrombin-stimulated events in cultured smooth muscle cells. J Biol Chem. 265:1990;17334-17340.
11. Huang C.L., Cogan M.G., Cragoe E.J., Ives H.E. Thrombin activation of the Na/H exchanger in vascular smooth muscle cells evidence for a kinase C-dependent pathway which is Ca dependent and pertussis toxin-sensitive . J Biol Chem. 262:1987;14134-14140.
12. Baim D.S. Stent thrombosis closing in on the best preventive treatment . Circulation. 95:1997;1098-1100.
13. Hasdai D., Garratt K.N., Holmes D.R. Jr, Berger P.B., Schwartz R.S., Bell M.R. Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol. 28:1996;361-367.
14. Yamamoto K., Ikeda U., Furuhashi K., Irokawa M., Nakayama T., Shimada K. The coagulation system is activated in idiopathic cardiomyopathy. J Am Coll Cardiol. 25:1995;1634-1640.
15. Yamamoto K., Ikeda U., Minezaki K., Fukazawa H., Mizuno O., Kim S., Fujikawa H., Sekiguchi H., Shimada K. Effect of mitral valvuloplasty in mitral stenosis on coagulation activity. Am J Cardiol. 79:1997;1131-1135.
16. Inoue T., Hoshi K., Fujito T., Sakai Y., Morooka S., Sohma R. Early detection of platelet activation after coronary angioplasty. Coron Artery Dis. 7:1996;529-534.
17. Marmur J.D., Rossikhina M., Guha A., Fyfe B., Friedrich V., Mendlewitz M., Nemerson Y., Taubman M.B. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest. 91:1993;2253-2259.
18. Oltrona L., Speidel C.M., Recchia D., Wickline S.A., Eisenberg P.R., Abendschein D.R. Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. Circulation. 96:1997;646-652.
19. Levin E.G., Loskutoff D.J. Cultured bovine endothelial cells produce both urokinase and tissue plasminogen activators. J Cell Biol. 94:1982;631-636.
20. Levin E.G., Marzec U., Anderson J., Harker L.A. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest. 74:1984;1988-1995.
21. Kluft C., Jie A.F., Rijken D.C., Verheijen J.H. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Thromb Haemost. 59:1988;329-332.
22. Watkins M.W., Luetmer P.A., Schneider D.J., Witmer W.T., Vaitkus P.T., Sobel B.E. Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions. Cathet Caridovasc Diagn. 44:1998;257-264.
23. Williams M.S., Coller B.S., Väänänen H.J., Schudder L.E., Sharma S.K., Marmur J.D. Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab;ReoPro). Circulation. 98:1998;742-748.
24. Ware J.A., Coller B.S. Platelet morphology, biochemistry, and function. Bentler Ernest, Beutler E., Lichtman M.A., Coller B.S., Kipps T.J. Hematology. 1995;1161-1201 McGraw-Hill, Inc.
25. Gregorini L., Marco J., Fajadet J., Bernies M., Cassagneau B., Brunel P., Bossi I.M., Mannucci P.M. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilatation procedures. J Am Coll Cardiol. 29:1997;13-20.